NYSE:ENOVMedical Equipment
Will Enovis’ (ENOV) Higher Revenue Outlook Offset Concerns About Continued Net Losses?
Enovis Corporation recently reported its second quarter 2025 results, showing sales of US$564.55 million and a net loss of US$36.74 million, and raised its full-year 2025 revenue guidance to between US$2.245 billion and US$2.275 billion.
Despite widening losses, management's decision to lift revenue expectations suggests increased confidence in the company's ability to grow sales in the current year.
We'll examine how Enovis's raised revenue outlook, despite ongoing net losses, may affect...